S-3 · 2026-11-10
Atara Biotherapeutics has filed a new S-3 registration statement to offer up to $200 million in securities, enhancing its financial flexibility.
| Name | Atara Biotherapeutics, Inc. |
|---|---|
| CIK | 0001604464 |
| Tickers | ATRA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 460920988 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 805-623-4211 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Atara Biotherapeutics has filed a new S-3 registration statement to offer up to $200 million in securities, enhancing its financial flexibility.
1136 filing rows loaded from submissions recent; extra archives: CIK0001604464-submissions-001.json (136 filings, 2014-04-10 to 2015-08-04).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 4 | FORM 4 | 0000905148-26-005037 | 5221 | ||||||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-005017 | 001-36548 | 261567916 | 33 | 5342 | |||
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-004975 | 001-36548 | 261562789 | 33 | 5971 | |||
| 2026-11-10 | S-3 | S-3 | 0001104659-26-125314 | 333-299967 | 261541346 | 33 | 1044632 | 1 | 1 | |
| 2026-11-10 | 10-Q | 10-Q | 0001104659-26-125192 | 001-36548 | 261540564 | 34 | 8498067 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001104659-26-125171 | 001-36548 | 261540440 | 34 | 379040 | 1 | 1 |
| 2026-09-04 | 4 | FORM 4 | 0000905148-26-004085 | 10910 | ||||||
| 2026-08-26 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-003961 | 001-36548 | 261324621 | 33 | 5933 | |||
| 2026-08-26 | 4 | FORM 4 | 0000905148-26-003960 | 11650 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005481 | 005-88393 | 261281296 | 34 | 12369 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-346885 | 001-36548 | 261267689 | 34 | 10978557 | 1 | 1 | |
| 2026-08-12 | 8-K | 8-K | 2.02 | 0001193125-26-346857 | 001-36548 | 261267565 | 34 | 455899 | 1 | 1 |
| 2026-07-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-086733 | 22729 | ||||||
| 2026-07-24 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-086728 | 005-88393 | 261202619 | 34 | 16170 | |||
| 2026-07-06 | 3 | FORM 3 | 0000905148-26-003168 | 3107 | ||||||
| 2026-06-26 | 8-K | 8-K | 5.02 | 0001193125-26-285498 | 001-36548 | 261129394 | 34 | 150222 | 1 | 1 |
| 2026-06-15 | 4 | FORM 4 | 0000905148-26-002951 | 4754 | ||||||
| 2026-06-15 | 3 | FORM 3 | 0000905148-26-002950 | 9813 | ||||||
| 2026-06-12 | S-8 | REGISTRATION STATEMENT | 0001213900-26-068286 | 333-296747 | 261087056 | 33 | 208784 | 1 | 1 | |
| 2026-06-12 | 8-K | CURRENT REPORT | 5.02,5.07 | 0001213900-26-068264 | 001-36548 | 261086605 | 34 | 213746 | 1 | 1 |
| 2026-06-11 | 4 | FORM 4 | 0000905148-26-002921 | 4834 | ||||||
| 2026-06-11 | 4 | FORM 4 | 0000905148-26-002920 | 4789 | ||||||
| 2026-06-11 | 4 | FORM 4 | 0000905148-26-002919 | 13754 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4.xml | 0000905148-26-002571 | 5223 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4.xml | 0000905148-26-002570 | 5190 | ||||||
| 2026-05-18 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-002507 | 001-36548 | 26994311 | 33 | 5951 | |||
| 2026-05-18 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-002506 | 001-36548 | 26994299 | 33 | 5906 | |||
| 2026-05-14 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-061506 | 005-88393 | 26981652 | 34 | 15768 | |||
| 2026-05-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002914 | 005-88393 | 26971199 | 34 | 15792 | |||
| 2026-05-12 | 424B5 | 424B5 | 0001193125-26-219518 | 333-275256 | 26968909 | 33 | 115953 | |||
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-219482 | 001-36548 | 26968764 | 34 | 17120142 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 9.01 | 0001193125-26-219420 | 001-36548 | 26968570 | 34 | 383697 | 1 | 1 |
| 2026-05-11 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-217389 | 005-88393 | 26964985 | 34 | 14592 | |||
| 2026-05-11 | 4 | 4 | 0001193125-26-217380 | 8829 | ||||||
| 2026-05-11 | 4 | xslF345X06/ownership.xml | 0000935836-26-000239 | 6936 | ||||||
| 2026-05-11 | 3 | xslF345X06/ownership.xml | 0000935836-26-000238 | 5273 | ||||||
| 2026-05-08 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002802 | 005-88393 | 26958415 | 34 | 17484 | |||
| 2026-05-07 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-212781 | 001-36548 | 26955648 | 33 | 4714 | |||
| 2026-05-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000935836-26-000230 | 005-88393 | 26955518 | 34 | 16606 | |||
| 2026-05-07 | 8-K | 8-K | 8.01 | 0001193125-26-210413 | 001-36548 | 26950977 | 34 | 165285 | 1 | 1 |
| 2026-05-01 | 8-K | 8-K | 3.01 | 0001193125-26-201397 | 001-36548 | 26932411 | 34 | 150832 | 1 | 1 |
| 2026-04-24 | DEF 14A | DEF 14A | 0001193125-26-177285 | 001-36548 | 26894161 | 34 | 3096832 | 1 | 1 | |
| 2026-04-24 | DEFA14A | DEFA14A | 0001193125-26-177280 | 001-36548 | 26894133 | 34 | 2019164 | |||
| 2026-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000930 | 333-294377 | 26794177 | 33 | 1752 | ||
| 2026-03-25 | 424B3 | 424B3 | 0001193125-26-124322 | 333-294377 | 26793430 | 33 | 134527 | |||
| 2026-03-23 | CORRESP | filename1.htm | 0001193125-26-119715 | 7425 | ||||||
| 2026-03-20 | UPLOAD | filename1.pdf | 0000000000-26-002840 | 333-294377 | 40132 | |||||
| 2026-03-19 | 4 | 4 | 0001193125-26-116060 | 12481 | ||||||
| 2026-03-17 | S-3 | S-3 | 0001193125-26-110849 | 333-294377 | 26762176 | 33 | 338674 | 1 | 1 | |
| 2026-03-16 | 424B5 | 424B5 | 0001193125-26-108386 | 333-275256 | 26757023 | 33 | 115937 | |||
| 2026-03-16 | 10-K | 10-K | 0001193125-26-108361 | 001-36548 | 26756876 | 34 | 14771437 | 1 | 1 | |
| 2026-03-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-108344 | 001-36548 | 26756777 | 34 | 397845 | 1 | 1 |
| 2026-03-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-103127 | 001-36548 | 26745735 | 34 | 165546 | 1 | 1 |
| 2026-03-11 | 4 | xslF345X05/form4.xml | 0000905148-26-001225 | 5150 | ||||||
| 2026-03-11 | 4 | xslF345X05/form4.xml | 0000905148-26-001224 | 5117 | ||||||
| 2026-03-04 | 4 | xslF345X05/form4.xml | 0000905148-26-001144 | 9413 | ||||||
| 2026-03-04 | 4 | xslF345X05/form4.xml | 0000905148-26-001143 | 9254 | ||||||
| 2026-03-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-086793 | 001-36548 | 26711140 | 34 | 144608 | 1 | 1 |
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-001102 | 001-36548 | 26710061 | 33 | 5328 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-001100 | 001-36548 | 26710055 | 33 | 5277 | |||
| 2026-02-23 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-26-062534 | 001-36548 | 26662171 | 34 | 283873 | 1 | 1 |
| 2026-01-14 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-013362 | 005-88393 | 26534569 | 34 | 17009 | |||
| 2026-01-14 | 4 | 4 | 0001193125-26-013358 | 8475 | ||||||
| 2026-01-12 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-010883 | 001-36548 | 26528281 | 33 | 6159 | |||
| 2026-01-12 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-010342 | 001-36548 | 26526663 | 34 | 155559 | 1 | 1 |
| 2026-01-02 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-000907 | 001-36548 | 26502310 | 34 | 150496 | 1 | 1 |
| 2025-12-01 | 4 | 4 | 0001193125-25-304018 | 12399 | ||||||
| 2025-11-19 | 4 | xslF345X05/form4.xml | 0000905148-25-004141 | 6377 | ||||||
| 2025-11-19 | 4 | xslF345X05/form4.xml | 0000905148-25-004140 | 7787 | ||||||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-004102 | 001-36548 | 251492266 | 33 | 4797 | |||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-004101 | 001-36548 | 251492256 | 33 | 4754 | |||
| 2025-11-14 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-112574 | 005-88393 | 251486661 | 34 | 36205 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000703 | 005-88393 | 251485837 | 34 | 16577 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-276219 | 001-36548 | 251469626 | 34 | 12182027 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-276209 | 001-36548 | 251469583 | 34 | 228931 | 1 | 1 |
| 2025-10-07 | 8-K | 8-K | 2.05 | 0001193125-25-232117 | 001-36548 | 251377764 | 34 | 132349 | 1 | 1 |
| 2025-09-04 | 8-K | 8-K | 5.02 | 0000950170-25-112898 | 001-36548 | 251291336 | 34 | 142600 | 1 | 1 |
| 2025-08-20 | 4 | xslF345X05/form4.xml | 0000905148-25-003070 | 7819 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4.xml | 0000905148-25-003069 | 7785 | ||||||
| 2025-08-19 | 4 | 4 | 0000950170-25-110310 | 7612 | ||||||
| 2025-08-19 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-110311 | 005-88393 | 251233576 | 34 | 17258 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-003038 | 001-36548 | 251228523 | 33 | 4798 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-003037 | 001-36548 | 251228481 | 33 | 4754 | |||
| 2025-08-11 | 10-Q | 10-Q | 0000950170-25-106550 | 001-36548 | 251202089 | 34 | 11343647 | 1 | 1 | |
| 2025-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-106533 | 001-36548 | 251201971 | 34 | 432245 | 1 | 1 |
| 2025-07-21 | 4 | 4 | 0000950170-25-097087 | 7101 | ||||||
| 2025-07-14 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-158719 | 001-36548 | 251121768 | 34 | 159899 | 1 | 1 |
| 2025-06-12 | 4 | xslF345X05/form4.xml | 0000905148-25-002142 | 4636 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4.xml | 0000905148-25-002141 | 4663 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4.xml | 0000905148-25-002140 | 4519 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4.xml | 0000905148-25-002139 | 4707 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4.xml | 0000905148-25-002138 | 4645 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4.xml | 0000905148-25-002137 | 4667 | ||||||
| 2025-06-11 | 8-K | 8-K | 5.07 | 0001193125-25-139150 | 001-36548 | 251040178 | 34 | 145959 | 1 | 1 |
| 2025-05-23 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-052422 | 005-88393 | 25982130 | 34 | 37845 | |||
| 2025-05-23 | 3 | OWNERSHIP DOCUMENT | 0001104659-25-052410 | 3432 | ||||||
| 2025-05-23 | 3 | OWNERSHIP DOCUMENT | 0001104659-25-052406 | 12349 | ||||||
| 2025-05-21 | 3 | 3 | 0000950170-25-075902 | 8242 | ||||||
| 2025-05-21 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-075903 | 005-88393 | 25974238 | 34 | 40385 | |||
| 2025-05-20 | 4 | xslF345X05/form4.xml | 0000905148-25-001866 | 4913 | ||||||
| 2025-05-20 | 4 | xslF345X05/form4.xml | 0000905148-25-001865 | 4945 | ||||||
| 2025-05-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-001838 | 001-36548 | 25961135 | 33 | 4797 | |||
| 2025-05-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-001837 | 001-36548 | 25961128 | 33 | 4750 | |||
| 2025-05-16 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-050119 | 005-88393 | 25961048 | 34 | 20011 | |||
| 2025-05-16 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-050116 | 13719 | ||||||
| 2025-05-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-121824 | 001-36548 | 25960705 | 34 | 625228 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-049700 | 005-88393 | 25956714 | 34 | 21759 | |||
| 2025-05-15 | 424B5 | 424B5 | 0001193125-25-120939 | 333-275256 | 25955774 | 33 | 1122425 | |||
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-072040 | 001-36548 | 25949002 | 34 | 10596299 | 1 | 1 | |
| 2025-05-15 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-25-120345 | 001-36548 | 25948980 | 34 | 233544 | 1 | 1 |
| 2025-05-12 | 8-K | 8-K | 2.05 | 0000950170-25-069198 | 001-36548 | 25934876 | 34 | 149743 | 1 | 1 |
| 2025-05-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-113811 | 001-36548 | 25917186 | 34 | 162023 | 1 | 1 |
| 2025-04-28 | DEFA14A | DEFA14A | 0000950170-25-059333 | 001-36548 | 25880666 | 34 | 288857 | |||
| 2025-04-28 | DEF 14A | DEF 14A | 0000950170-25-059322 | 001-36548 | 25880541 | 34 | 4790854 | 1 | 1 | |
| 2025-04-10 | 3 | xslF345X02/form3.xml | 0000905148-25-001196 | 18830 | ||||||
| 2025-04-04 | 8-K | 8-K | 1.01 | 0000950170-25-051121 | 001-36548 | 25814660 | 34 | 149689 | 1 | 1 |
| 2025-04-02 | 4 | xslF345X05/form4.xml | 0000905148-25-001058 | 24643 | ||||||
| 2025-03-31 | 8-K | 8-K | 5.02 | 0001193125-25-068789 | 001-36548 | 25793684 | 34 | 142672 | 1 | 1 |
| 2025-03-07 | 10-K | 10-K | 0000950170-25-035507 | 001-36548 | 25720159 | 34 | 14447101 | 1 | 1 | |
| 2025-03-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-035482 | 001-36548 | 25719974 | 34 | 464167 | 1 | 1 |
| 2025-03-05 | 4 | xslF345X05/form4.xml | 0000905148-25-000865 | 4936 | ||||||
| 2025-03-05 | 4 | xslF345X05/form4.xml | 0000905148-25-000864 | 4909 | ||||||
| 2025-03-05 | 4 | xslF345X05/form4.xml | 0000905148-25-000863 | 5097 | ||||||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-000812 | 001-36548 | 25700587 | 33 | 4311 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-000811 | 001-36548 | 25700567 | 33 | 4272 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-000810 | 001-36548 | 25700557 | 33 | 4256 | |||
| 2025-03-03 | 8-K | 8-K | 2.05,9.01 | 0000950170-25-030832 | 001-36548 | 25697747 | 34 | 182386 | 1 | 1 |
| 2025-02-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-015605 | 005-88393 | 25598690 | 34 | 282304 | |||
| 2025-01-29 | 4 | xslF345X05/form4.xml | 0000905148-25-000245 | 5181 | ||||||
| 2025-01-27 | 8-K | 8-K | 2.05,9.01 | 0000950170-25-009225 | 001-36548 | 25559428 | 34 | 156819 | 1 | 1 |
| 2025-01-21 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-006992 | 001-36548 | 25540437 | 34 | 181518 | 1 | 1 |
| 2025-01-17 | S-8 | S-8 | 0001193125-25-008413 | 333-284338 | 25538718 | 33 | 78678 | |||
| 2025-01-16 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-25-006191 | 001-36548 | 25535763 | 34 | 196931 | 1 | 1 |
| 2024-12-23 | 8-K | 8-K | 5.03,9.01 | 0001193125-24-284167 | 001-36548 | 241573502 | 34 | 391277 | 1 | 1 |
| 2024-11-20 | 4 | xslF345X05/form4.xml | 0000905148-24-003243 | 4986 | ||||||
| 2024-11-20 | 4 | xslF345X05/form4.xml | 0000905148-24-003242 | 4989 | ||||||
| 2024-11-20 | 4 | xslF345X05/form4.xml | 0000905148-24-003241 | 5016 | ||||||
| 2024-11-18 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-003232 | 001-36548 | 241472723 | 33 | 4892 | |||
| 2024-11-18 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-003231 | 001-36548 | 241472704 | 33 | 4880 | |||
| 2024-11-18 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-003230 | 001-36548 | 241472698 | 33 | 4858 | |||
| 2024-11-18 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-003229 | 001-36548 | 241472681 | 33 | 4836 | |||
| 2024-11-14 | SC 13G/A | atra13ga1.htm | 0000935836-24-000720 | 005-88393 | 241464902 | 34 | 48376 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-118959 | 005-88393 | 241462652 | 34 | 136670 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-125389 | 001-36548 | 241448177 | 34 | 8630481 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-24-125334 | 001-36548 | 241447929 | 34 | 437151 | 1 | 1 |
| 2024-11-12 | SC 13G/A | UnitedStates_13G__AtaraBioth.txt | 0000932471-24-000879 | 005-88393 | 241446550 | 34 | 6593 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__AtaraBioth.txt | 0000932471-24-000340 | 005-88393 | 241421495 | 34 | 5654 | |||
| 2024-10-15 | 8-K | 8-K | 5.02 | 0001193125-24-237582 | 001-36548 | 241371891 | 34 | 145577 | 1 | 1 |
| 2024-09-13 | SC 13G/A | SC 13G/A | 0001104659-24-099749 | 005-88393 | 241297670 | 34 | 92364 | |||
| 2024-09-11 | 4 | xslF345X05/form4.xml | 0000905148-24-002545 | 5239 | ||||||
| 2024-09-05 | 3 | OWNERSHIP DOCUMENT | 0001104659-24-097458 | 11681 | ||||||
| 2024-09-05 | SC 13D/A | SC 13D/A | 0001104659-24-097369 | 005-88393 | 241281462 | 34 | 70618 | |||
| 2024-09-04 | 424B5 | 424B5 | 0001193125-24-213178 | 333-275256 | 241278113 | 33 | 644776 | |||
| 2024-09-03 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-24-212168 | 001-36548 | 241274902 | 34 | 494620 | 1 | 1 |
| 2024-08-20 | 4 | xslF345X05/form4.xml | 0000905148-24-002306 | 6664 | ||||||
| 2024-08-20 | 4 | xslF345X05/form4.xml | 0000905148-24-002305 | 8038 | ||||||
| 2024-08-20 | 4 | xslF345X05/form4.xml | 0000905148-24-002304 | 8164 | ||||||
| 2024-08-20 | 4 | xslF345X05/form4.xml | 0000905148-24-002303 | 6587 | ||||||
| 2024-08-20 | 4 | xslF345X05/form4.xml | 0000905148-24-002302 | 6697 | ||||||
| 2024-08-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-002274 | 001-36548 | 241216819 | 33 | 4937 | |||
| 2024-08-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-002273 | 001-36548 | 241216797 | 33 | 4841 | |||
| 2024-08-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-002272 | 001-36548 | 241216783 | 33 | 4877 | |||
| 2024-08-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-002271 | 001-36548 | 241216768 | 33 | 4861 | |||
| 2024-08-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-002270 | 001-36548 | 241216739 | 33 | 4840 | |||
| 2024-08-14 | 4 | xslF345X05/form4.xml | 0000905148-24-002244 | 10121 | ||||||
| 2024-08-12 | 10-Q | 10-Q | 0000950170-24-095533 | 001-36548 | 241197877 | 34 | 8368837 | 1 | 1 | |
| 2024-08-12 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-24-095526 | 001-36548 | 241197820 | 34 | 786247 | 1 | 1 |
| 2024-07-17 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-180371 | 001-36548 | 241122414 | 34 | 166172 | 1 | 1 |
| 2024-07-08 | SC 13G/A | us0465131078_070824.txt | 0001086364-24-008257 | 005-88393 | 241105237 | 34 | 12653 | |||
| 2024-06-20 | 8-K | 8-K | 3.03,5.03,9.01 | 0001193125-24-164554 | 001-36548 | 241057338 | 34 | 165555 | 1 | 1 |
| 2024-06-17 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-162069 | 001-36548 | 241047020 | 34 | 162349 | 1 | 1 |
| 2024-06-11 | S-8 | S-8 | 0001193125-24-159220 | 333-280126 | 241036648 | 33 | 124912 | |||
| 2024-06-11 | S-8 | S-8 | 0001193125-24-159213 | 333-280125 | 241036609 | 33 | 212260 | |||
| 2024-06-11 | 8-K | 8-K | 5.07 | 0001193125-24-158461 | 001-36548 | 241033901 | 34 | 170044 | 1 | 1 |
| 2024-05-22 | SC 13D | SC 13D | 0001104659-24-064358 | 005-88393 | 24974696 | 34 | 147000 | |||
| 2024-05-20 | 4 | xslF345X05/form4.xml | 0000905148-24-001561 | 5049 | ||||||
| 2024-05-20 | 4 | xslF345X05/form4.xml | 0000905148-24-001560 | 4981 | ||||||
| 2024-05-20 | 4 | xslF345X05/form4.xml | 0000905148-24-001559 | 5007 | ||||||
| 2024-05-20 | 4 | xslF345X05/form4.xml | 0000905148-24-001558 | 4971 | ||||||
| 2024-05-20 | 4 | xslF345X05/form4.xml | 0000905148-24-001557 | 4980 | ||||||
| 2024-05-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-001501 | 001-36548 | 24957536 | 33 | 4939 | |||
| 2024-05-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-001500 | 001-36548 | 24957528 | 33 | 4839 | |||
| 2024-05-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-001499 | 001-36548 | 24957527 | 33 | 4873 | |||
| 2024-05-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-001498 | 001-36548 | 24957526 | 33 | 4859 | |||
| 2024-05-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-001497 | 001-36548 | 24957525 | 33 | 4836 | |||
| 2024-05-16 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-001496 | 001-36548 | 24957497 | 33 | 16735 | |||
| 2024-05-10 | DEFR14A | DEFR14A | 0001193125-24-136215 | 001-36548 | 24935451 | 34 | 19246 | |||
| 2024-05-09 | 10-Q | 10-Q | 0000950170-24-056959 | 001-36548 | 24930700 | 34 | 7707153 | 1 | 1 | |
| 2024-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-056901 | 001-36548 | 24930464 | 34 | 398537 | 1 | 1 |
| 2024-04-26 | DEFA14A | DEFA14A | 0000950170-24-049170 | 001-36548 | 24884084 | 34 | 378506 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-049147 | 001-36548 | 24883956 | 34 | 4803579 | 1 | 1 | |
| 2024-04-12 | PRE 14A | PRE 14A | 0000950170-24-044046 | 001-36548 | 24841645 | 34 | 3970920 | 1 | 1 | |
| 2024-04-02 | 4 | xslF345X05/form4.xml | 0000905148-24-001060 | 4541 | ||||||
| 2024-04-02 | 4 | xslF345X05/form4.xml | 0000905148-24-001059 | 4543 | ||||||
| 2024-04-02 | 4 | xslF345X05/form4.xml | 0000905148-24-001058 | 4582 | ||||||
| 2024-04-02 | 4 | xslF345X05/form4.xml | 0000905148-24-001057 | 4795 | ||||||
| 2024-04-02 | 4 | xslF345X05/form4.xml | 0000905148-24-001056 | 4523 | ||||||
| 2024-03-29 | 8-K | 8-K | 5.02 | 0000950170-24-038690 | 001-36548 | 24804420 | 34 | 147547 | 1 | 1 |
| 2024-03-28 | 10-K | 10-K | 0000950170-24-037644 | 001-36548 | 24793778 | 34 | 14473722 | 1 | 1 | |
| 2024-03-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-037643 | 001-36548 | 24793716 | 34 | 456419 | 1 | 1 |
| 2024-03-18 | SC 13G | SC 13G | 0001104659-24-035552 | 005-88393 | 24759173 | 34 | 145664 | |||
| 2024-03-06 | 4 | xslF345X05/form4.xml | 0000905148-24-000911 | 5050 | ||||||
| 2024-03-06 | 4 | xslF345X05/form4.xml | 0000905148-24-000910 | 4982 | ||||||
| 2024-03-06 | 4 | xslF345X05/form4.xml | 0000905148-24-000909 | 5008 | ||||||
| 2024-03-06 | 4 | xslF345X05/form4.xml | 0000905148-24-000908 | 6415 | ||||||
| 2024-03-06 | 4 | xslF345X05/form4.xml | 0000905148-24-000907 | 4980 | ||||||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-000882 | 001-36548 | 24717810 | 33 | 16630 | |||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-000881 | 001-36548 | 24717804 | 33 | 16522 | |||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-000880 | 001-36548 | 24717801 | 33 | 16526 | |||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-000879 | 001-36548 | 24717798 | 33 | 16526 | |||
| 2024-03-04 | 144 | xsl144X01/primary_doc.xml | 0000905148-24-000878 | 001-36548 | 24717786 | 33 | 16546 | |||
| 2024-02-23 | 8-K | 8-K | 5.02 | 0000950170-24-019416 | 001-36548 | 24671685 | 34 | 148488 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036542 | 005-88393 | 24640203 | 34 | 78496 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023785 | 005-88393 | 24638934 | 34 | 75951 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020351 | 005-88393 | 24627411 | 34 | 13120 | |||
| 2024-02-09 | SC 13G/A | atra224.txt | 0000814133-24-000060 | 005-88393 | 24615349 | 34 | 4161 | |||
| 2024-02-06 | SC 13G/A | ATARA.txt | 0000769993-24-000055 | 005-88393 | 24600889 | 34 | 23770 | |||
| 2024-01-26 | SC 13G/A | us0465131078_012624.txt | 0001086364-24-004860 | 005-88393 | 24569157 | 34 | 13473 | |||
| 2024-01-22 | SC 13G/A | Atara_Bio_Inc.txt | 0000093751-24-000070 | 005-88393 | 24548076 | 34 | 8510 | |||
| 2024-01-09 | 4 | xslF345X05/form4.xml | 0000905148-24-000115 | 5219 | ||||||
| 2024-01-09 | 4 | xslF345X05/form4.xml | 0000905148-24-000114 | 5150 | ||||||
| 2024-01-09 | 4 | xslF345X05/form4.xml | 0000905148-24-000113 | 5357 | ||||||
| 2024-01-09 | 4 | xslF345X05/form4.xml | 0000905148-24-000112 | 5140 | ||||||
| 2024-01-09 | 4 | xslF345X05/form4.xml | 0000905148-24-000111 | 5330 | ||||||
| 2024-01-09 | 424B5 | 424B5 | 0001193125-24-005223 | 333-275256 | 24523595 | 33 | 639930 | |||
| 2024-01-09 | SC 13G/A | NONE | 0001567619-24-000004 | 005-88393 | 24523521 | 34 | 117125 | |||
| 2024-01-09 | 8-K | 8-K | 1.01,3.01,9.01 | 0001193125-24-005188 | 001-36548 | 24523230 | 34 | 482003 | 1 | 1 |
| 2024-01-08 | 8-K | 8-K | 2.05,5.02,7.01,8.01,9.01 | 0001193125-24-003945 | 001-36548 | 24518449 | 34 | 2888684 | 1 | 1 |
| 2024-01-03 | S-8 | S-8 | 0001193125-24-001495 | 333-276360 | 24506409 | 33 | 82542 | |||
| 2023-12-20 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-071896 | 001-36548 | 231501659 | 34 | 177332 | 1 | 1 |
| 2023-12-07 | SC 13G/A | FILING ATARA BIOTHERAPEUTICS, INC. | 0000019617-23-000584 | 005-88393 | 34 | 89931 | ||||
| 2023-11-21 | SC 13G | atra13g.htm | 0000935836-23-000715 | 005-88393 | 231424066 | 34 | 47967 | |||
| 2023-11-20 | 4 | xslF345X05/form4.xml | 0000905148-23-001513 | 4959 | ||||||
| 2023-11-20 | 4 | xslF345X05/form4.xml | 0000905148-23-001512 | 4891 | ||||||
| 2023-11-20 | 4 | xslF345X05/form4.xml | 0000905148-23-001511 | 4917 | ||||||
| 2023-11-20 | 4 | xslF345X05/form4.xml | 0000905148-23-001510 | 4884 | ||||||
| 2023-11-20 | 4 | xslF345X05/form4.xml | 0000905148-23-001509 | 4882 | ||||||
| 2023-11-20 | 4 | xslF345X05/form4.xml | 0000905148-23-001508 | 4890 | ||||||
| 2023-11-17 | 424B3 | 424B3 | 0001193125-23-279824 | 333-275256 | 231419252 | 33 | 190298 | |||
| 2023-11-15 | 4 | xslF345X05/form4.xml | 0000905148-23-001457 | 6319 | ||||||
| 2023-11-14 | 4 | xslF345X05/form4.xml | 0000905148-23-001450 | 4711 | ||||||
| 2023-11-14 | 4 | xslF345X05/form4.xml | 0000905148-23-001449 | 4701 | ||||||
| 2023-11-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-11-13 16:30:00 | 9999999995-23-003308 | 333-275256 | 231401274 | 33 | 1757 | ||
| 2023-11-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-273808 | 001-36548 | 231389754 | 34 | 166917 | 1 | 1 |
| 2023-11-08 | CORRESP | filename1.htm | 0001193125-23-273647 | 8110 | ||||||
| 2023-11-06 | UPLOAD | filename1.pdf | 0000000000-23-012129 | 40323 | ||||||
| 2023-11-01 | S-3 | S-3 | 0001193125-23-268364 | 333-275256 | 231369284 | 33 | 658489 | |||
| 2023-11-01 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-268185 | 001-36548 | 231368193 | 34 | 371549 | 1 | 1 |
| 2023-11-01 | 10-Q | 10-Q | 0000950170-23-057147 | 001-36548 | 231366701 | 34 | 10058635 | 1 | 1 | |
| 2023-11-01 | 8-K | 8-K | 1.01,2.02,2.05,9.01 | 0000950170-23-057146 | 001-36548 | 231366686 | 34 | 506811 | 1 | 1 |
| 2023-09-20 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-237762 | 001-36548 | 231264947 | 34 | 162139 | 1 | 1 |
| 2023-08-18 | 4 | xslF345X05/form4.xml | 0001140361-23-040564 | 6343 | ||||||
| 2023-08-18 | 4 | xslF345X05/form4.xml | 0001140361-23-040563 | 6555 | ||||||
| 2023-08-18 | 4 | xslF345X05/form4.xml | 0001140361-23-040562 | 6421 | ||||||
| 2023-08-18 | 4 | xslF345X05/form4.xml | 0001140361-23-040561 | 6357 | ||||||
| 2023-08-18 | 4 | xslF345X05/form4.xml | 0001140361-23-040560 | 6349 | ||||||
| 2023-08-18 | 4 | xslF345X05/form4.xml | 0001140361-23-040559 | 6355 | ||||||
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039820 | 001-36548 | 231151458 | 34 | 10614474 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-039797 | 001-36548 | 231151284 | 34 | 559754 | 1 | 1 |
| 2023-06-29 | 4 | xslF345X04/form4.xml | 0001140361-23-032216 | 4561 | ||||||
| 2023-06-09 | 3 | xslF345X02/form3.xml | 0001140361-23-029142 | 18334 | ||||||
| 2023-06-09 | 3 | xslF345X02/form3.xml | 0001140361-23-029141 | 16705 | ||||||
| 2023-06-09 | 3 | xslF345X02/form3.xml | 0001140361-23-029143 | 23961 | ||||||
| 2023-06-09 | 8-K | 8-K | 5.02 | 0000950170-23-027257 | 001-36548 | 231005270 | 34 | 165540 | 1 | 1 |
| 2023-06-05 | 8-K | 8-K | 5.02,5.07 | 0000950170-23-026351 | 001-36548 | 23992479 | 34 | 205965 | 1 | 1 |
| 2023-06-02 | 4 | xslF345X04/form4.xml | 0001140361-23-028161 | 16777 | ||||||
| 2023-06-02 | 4 | xslF345X04/form4.xml | 0001140361-23-028154 | 13985 | ||||||
| 2023-06-02 | 4 | xslF345X04/form4.xml | 0001140361-23-028153 | 12085 | ||||||
| 2023-06-02 | 4 | xslF345X04/form4.xml | 0001140361-23-028152 | 12554 | ||||||
| 2023-06-02 | 4 | xslF345X04/form4.xml | 0001140361-23-028150 | 12164 | ||||||
| 2023-06-02 | 4 | xslF345X04/form4.xml | 0001140361-23-028151 | 12783 | ||||||
| 2023-06-02 | 4 | xslF345X04/form4.xml | 0001140361-23-028149 | 12556 | ||||||
| 2023-05-18 | 4 | xslF345X04/form4.xml | 0001140361-23-025560 | 6371 | ||||||
| 2023-05-18 | 4 | xslF345X04/form4.xml | 0001140361-23-025561 | 4945 | ||||||
| 2023-05-18 | 4 | xslF345X04/form4.xml | 0001140361-23-025559 | 4970 | ||||||
| 2023-05-18 | 4 | xslF345X04/form4.xml | 0001140361-23-025558 | 6336 | ||||||
| 2023-05-12 | 8-K | 8-K | 5.02 | 0000950170-23-021809 | 001-36548 | 23916352 | 34 | 165610 | 1 | 1 |
| 2023-05-08 | 10-Q | 10-Q | 0000950170-23-018820 | 001-36548 | 23897912 | 34 | 9618711 | 1 | 1 | |
| 2023-05-08 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-23-018793 | 001-36548 | 23897739 | 34 | 456693 | 1 | 1 |
| 2023-05-02 | UPLOAD | filename1.pdf | 0000000000-23-004518 | 39783 | ||||||
| 2023-04-21 | CORRESP | filename1.htm | 0001193125-23-110534 | 74128 | ||||||
| 2023-04-07 | 3 | xslF345X02/form3.xml | 0001140361-23-017346 | 21921 | ||||||
| 2023-04-07 | DEFA14A | DEFA14A | 0000950170-23-012206 | 001-36548 | 23809054 | 34 | 4276819 | |||
| 2023-04-07 | DEF 14A | DEF 14A | 0000950170-23-012204 | 001-36548 | 23809027 | 34 | 6300831 | 1 | 1 | |
| 2023-03-31 | 8-K | 8-K | 5.02 | 0000950170-23-011416 | 001-36548 | 23788340 | 34 | 177402 | 1 | 1 |
| 2023-03-27 | UPLOAD | filename1.pdf | 0000000000-23-003045 | 52277 | ||||||
| 2023-03-24 | PRE 14A | PRE 14A | 0000950170-23-009724 | 001-36548 | 23759913 | 34 | 5520419 | 1 | 1 | |
| 2023-03-10 | 8-K | 8-K | 7.01 | 0001193125-23-067628 | 001-36548 | 23723954 | 34 | 143023 | 1 | 1 |
| 2023-03-06 | 4 | FORM 4 | 0001567619-23-004540 | 5167 | ||||||
| 2023-03-06 | 4 | FORM 4 | 0001567619-23-004539 | 5166 | ||||||
| 2023-03-06 | 4 | FORM 4 | 0001567619-23-004538 | 5168 | ||||||
| 2023-03-06 | 4 | FORM 4 | 0001567619-23-004537 | 5147 | ||||||
| 2023-03-03 | 4 | xslF345X03/form4.xml | 0001140361-23-010102 | 7027 | ||||||
| 2023-03-03 | 4 | xslF345X03/form4.xml | 0001140361-23-010104 | 7002 | ||||||
| 2023-03-03 | 4 | xslF345X03/form4.xml | 0001140361-23-010100 | 6966 | ||||||
| 2023-03-03 | 4 | xslF345X03/form4.xml | 0001140361-23-010097 | 7164 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021653 | 005-88393 | 23629666 | 34 | 77505 | |||
| 2023-02-14 | SC 13G/A | SCHEDULE 13G/A, AMENDMENT #2 | 0000899140-23-000372 | 005-88393 | 23628855 | 34 | 70649 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-037206 | 005-88393 | 23622434 | 34 | 78782 | |||
| 2023-02-13 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-23-028807,2023-02-13 | 9999999995-23-000387 | 333-253731 | 23621657 | 33 | 1769 | ||
| 2023-02-09 | 4 | FORM 4 | 0001567619-23-002174 | 4818 | ||||||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015376 | 005-88393 | 23602468 | 34 | 13040 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001406 | 005-88393 | 23601268 | 34 | 8183 | |||
| 2023-02-09 | POS AM | POS AM | 0001193125-23-028807 | 333-253731 | 23600729 | 33 | 537844 | |||
| 2023-02-09 | S-8 | S-8 | 0001193125-23-028606 | 333-269647 | 23600244 | 33 | 88230 | |||
| 2023-02-08 | 10-K | 10-K | 0000950170-23-002185 | 001-36548 | 23599828 | 34 | 17034348 | 1 | 1 | |
| 2023-02-08 | POSASR | POSASR | 0001193125-23-028491 | 333-253731 | 23599703 | 33 | 576175 | |||
| 2023-02-08 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-23-002132 | 001-36548 | 23599023 | 34 | 589516 | 1 | 1 |
| 2023-02-08 | SC 13G | atra223.txt | 0000814133-23-000032 | 005-88393 | 23598922 | 34 | 4025 | |||
| 2023-02-07 | SC 13G | ATARA_BIOTHERAPEUTICS.txt | 0000769993-23-000046 | 005-88393 | 23591739 | 34 | 23544 | |||
| 2023-02-03 | SC 13G | Atara_Biotherapeutics_Inc.txt | 0000093751-23-000187 | 005-88393 | 23585610 | 34 | 10416 | |||
| 2023-01-24 | SC 13G/A | us0465131078_012423.txt | 0001306550-23-002917 | 005-88393 | 23547354 | 34 | 13471 | |||
| 2023-01-18 | SC 13G/A | FILING ATARA BIOTHERAPEUTICS, INC. | 0000019617-23-000093 | 005-88393 | 34 | 89884 | ||||
| 2023-01-06 | 8-K | 8-K | 2.03 | 0001193125-23-003555 | 001-36548 | 23515267 | 34 | 142450 | 1 | 1 |
| 2022-12-20 | 8-K | 8-K | 1.01 | 0001193125-22-309181 | 001-36548 | 221475351 | 34 | 145458 | 1 | 1 |
| 2022-12-19 | 8-K | 8-K | 5.02,8.01 | 0001193125-22-307898 | 001-36548 | 221469649 | 34 | 144583 | 1 | 1 |
| 2022-12-16 | 3 | FORM 3 | 0001567619-22-021742 | 11387 | ||||||
| 2022-11-18 | 4 | xslF345X03/form4.xml | 0001140361-22-042381 | 11850 | ||||||
| 2022-11-18 | 4 | xslF345X03/form4.xml | 0001140361-22-042380 | 12588 | ||||||
| 2022-11-18 | 4 | xslF345X03/form4.xml | 0001140361-22-042379 | 12352 | ||||||
| 2022-11-18 | 4 | xslF345X03/form4.xml | 0001140361-22-042378 | 11912 | ||||||
| 2022-11-08 | 10-Q | 10-Q | 0000950170-22-023248 | 001-36548 | 221369201 | 34 | 11294022 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023226 | 001-36548 | 221369056 | 34 | 657836 | 1 | 1 |
| 2022-09-28 | 8-K | 8-K | 1.01 | 0001193125-22-253304 | 001-36548 | 221276447 | 34 | 143202 | 1 | 1 |
| 2022-09-27 | 8-K | 8-K | 5.03,9.01 | 0001193125-22-252141 | 001-36548 | 221271150 | 34 | 382992 | 1 | 1 |
| 2022-08-18 | 4 | FORM 4 | 0001140361-22-030302 | 4886 | ||||||
| 2022-08-18 | 4 | FORM 4 | 0001140361-22-030300 | 4824 | ||||||
| 2022-08-18 | 4 | FORM 4 | 0001140361-22-030299 | 6461 | ||||||
| 2022-08-18 | 4 | FORM 4 | 0001140361-22-030297 | 4845 | ||||||
| 2022-08-08 | 10-Q | 10-Q | 0000950170-22-015536 | 001-36548 | 221144543 | 34 | 10415664 | 1 | 1 | |
| 2022-08-08 | 8-K | 8-K | 1.01,2.02,2.05,5.02,9.01 | 0000950170-22-015519 | 001-36548 | 221144400 | 34 | 636367 | 1 | 1 |
| 2022-07-22 | S-8 | S-8 | 0001193125-22-200029 | 333-266288 | 221100038 | 33 | 190119 | |||
| 2022-06-29 | 4 | FORM 4 | 0001567619-22-013481 | 4814 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024166 | 6966 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024165 | 6714 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024164 | 6712 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024163 | 6707 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024162 | 6753 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024161 | 6679 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024160 | 6703 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024159 | 6724 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001140361-22-024158 | 10648 | ||||||
| 2022-06-24 | 8-K | 8-K | 5.07 | 0001193125-22-181461 | 001-36548 | 221039998 | 34 | 155366 | 1 | 1 |
| 2022-06-10 | 4 | FORM 4 | 0001567619-22-012667 | 4991 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001140361-22-019990 | 6298 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001140361-22-019988 | 6297 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001140361-22-019981 | 4837 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001140361-22-019978 | 4899 | ||||||
| 2022-05-19 | 8-K | 8-K | 1.02 | 0001193125-22-155021 | 001-36548 | 22942833 | 34 | 149809 | 1 | 1 |
| 2022-05-05 | 10-Q | 10-Q | 0001564590-22-018253 | 001-36548 | 22896409 | 34 | 8360770 | 1 | 1 | |
| 2022-05-05 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-018241 | 001-36548 | 22896143 | 34 | 484870 | 1 | 1 |
| 2022-04-27 | DEFA14A | DEFA14A | 0001564590-22-016099 | 001-36548 | 22860296 | 34 | 1565311 | |||
| 2022-04-27 | DEF 14A | DEF 14A | 0001564590-22-016087 | 001-36548 | 22860124 | 34 | 3054602 | |||
| 2022-04-04 | 8-K | 8-K | 2.01,9.01 | 0001193125-22-095073 | 001-36548 | 22802107 | 34 | 623034 | 1 | 1 |
| 2022-03-11 | SC 13G/A | SC 13G/A | 0001193125-22-073533 | 005-88393 | 22733964 | 34 | 79319 | |||
| 2022-03-03 | 4 | FORM 4 | 0001140361-22-007767 | 10353 | ||||||
| 2022-03-03 | 4 | FORM 4 | 0001140361-22-007765 | 8892 | ||||||
| 2022-03-03 | 4 | FORM 4 | 0001140361-22-007766 | 6989 | ||||||
| 2022-03-03 | 4 | FORM 4 | 0001140361-22-007764 | 8954 | ||||||
| 2022-03-03 | 4 | FORM 4 | 0001140361-22-007763 | 10614 | ||||||
| 2022-02-28 | S-8 | FORM S-8 | 0001193125-22-058338 | 333-263109 | 22691707 | 33 | 79721 | |||
| 2022-02-28 | 10-K | 10-K | 0001564590-22-007633 | 001-36548 | 22690005 | 34 | 19012908 | 1 | 1 | |
| 2022-02-28 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-007610 | 001-36548 | 22689338 | 34 | 539170 | 1 | 1 |
| 2022-02-18 | 8-K | 8-K | 8.01 | 0001193125-22-046032 | 001-36548 | 22650882 | 34 | 147569 | 1 | 1 |
| 2022-02-15 | SC 13G/A | SC 13G/A | 0001193125-22-042462 | 005-88393 | 22636150 | 34 | 79935 | |||
| 2022-02-14 | 4 | FORM 4 | 0001567619-22-004499 | 8531 | ||||||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-023132 | 005-88393 | 22634479 | 34 | 76583 | |||
| 2022-02-14 | SC 13G/A | SCHEDULE 13G (AMENDMENT NO. 1) | 0000899140-22-000307 | 005-88393 | 22632823 | 34 | 63893 | |||
| 2022-02-09 | SC 13G/A | NONE | 0001567619-22-003064 | 005-88393 | 22608263 | 34 | 117204 | |||
| 2022-02-09 | 4 | FORM 4 | 0001567619-22-003052 | 5620 | ||||||
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-016551 | 005-88393 | 22606517 | 34 | 13033 | |||
| 2022-02-09 | SC 13G | filing.txt | 0000315066-22-000800 | 005-88393 | 22604072 | 34 | 8437 | |||
| 2022-02-03 | SC 13G/A | us0465131078_020322.txt | 0000834237-22-006384 | 005-88393 | 22589133 | 34 | 13469 | |||
| 2022-01-26 | 8-K | 8-K | 1.01,2.02,5.02,9.01 | 0001193125-22-018422 | 001-36548 | 22558881 | 34 | 182586 | 1 | 1 |
| 2022-01-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-005158 | 001-36548 | 22519846 | 34 | 7303522 | 1 | 1 |
| 2022-01-07 | SC 13G/A | FILING ATARA BIOTHERAPEUTICS, INC. | 0000019617-22-000035 | 005-88393 | 34 | 89979 | ||||
| 2022-01-05 | 4 | FORM 4 | 0001567619-22-000568 | 8531 | ||||||
| 2021-12-21 | SC 13G | SCHEDULE 13G | 0000899140-21-000770 | 005-88393 | 211510200 | 34 | 67268 | |||
| 2021-12-03 | 4 | FORM 4 | 0001567619-21-021583 | 8925 | ||||||
| 2021-11-26 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-341306 | 001-36548 | 211452292 | 34 | 356322 | 1 | 1 |
| 2021-11-26 | 424B5 | 424B5 | 0001193125-21-341305 | 333-253731 | 211452287 | 33 | 495589 | |||
| 2021-11-18 | 4 | FORM 4 | 0001567619-21-020781 | 5432 | ||||||
| 2021-11-18 | 4 | FORM 4 | 0001567619-21-020780 | 5428 | ||||||
| 2021-11-18 | 4 | FORM 4 | 0001567619-21-020779 | 5435 | ||||||
| 2021-11-18 | 4 | FORM 4 | 0001567619-21-020778 | 5434 | ||||||
| 2021-11-18 | 4 | FORM 4 | 0001567619-21-020777 | 5416 | ||||||
| 2021-11-17 | 4 | FORM 4 | 0001567619-21-020653 | 11036 | ||||||
| 2021-11-05 | 4 | FORM 4 | 0001567619-21-019403 | 4672 | ||||||
| 2021-11-04 | 4 | FORM 4 | 0001567619-21-019331 | 8529 | ||||||
| 2021-11-04 | 10-Q | 10-Q | 0001564590-21-054261 | 001-36548 | 211378126 | 34 | 7968810 | 1 | 1 | |
| 2021-11-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-054254 | 001-36548 | 211378084 | 34 | 537450 | 1 | 1 |
| 2021-10-04 | 8-K | 8-K | 1.01 | 0001193125-21-290388 | 001-36548 | 211301056 | 34 | 149884 | 1 | 1 |
| 2021-09-29 | S-8 | S-8 | 0001193125-21-286789 | 333-259882 | 211292009 | 33 | 184879 | |||
| 2021-09-24 | 4 | FORM 4 | 0001567619-21-017578 | 10654 | ||||||
| 2021-09-17 | 4 | FORM 4 | 0001567619-21-017260 | 5122 | ||||||
| 2021-08-31 | 4 | FORM 4 | 0001567619-21-016517 | 4727 | ||||||
| 2021-08-19 | 4 | FORM 4 | 0001567619-21-016151 | 5168 | ||||||
| 2021-08-19 | 4 | FORM 4 | 0001567619-21-016150 | 5164 | ||||||
| 2021-08-19 | 4 | FORM 4 | 0001567619-21-016149 | 5171 | ||||||
| 2021-08-19 | 4 | FORM 4 | 0001567619-21-016148 | 5170 |
One latest value per concept from companyfacts (422 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 10.19M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 38.73M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 789,045 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177285 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.04M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177285 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 22.06 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-24 | 0001193125-26-177285 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 0 | 2026-11-09 | S-3 | 2026-11-10 | 0001104659-26-125314 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 0 | 2026-11-09 | S-3 | 2026-11-10 | 0001104659-26-125314 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 200.00M | 2026-11-09 | S-3 | 2026-11-10 | 0001104659-26-125314 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-09 | S-3 | 2026-11-10 | 0001104659-26-125314 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-09 | S-3 | 2026-11-10 | 0001104659-26-125314 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 762,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 691,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | AccretionExpense | Accretion Expense | USD | 276,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 1,000 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 641,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039820 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 2.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | AccruedRoyaltiesCurrentAndNoncurrent | Accrued Royalties | USD | 32.09M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039820 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 1.56M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 213,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 7.34M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001564590-14-005463 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 2.00B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 2.77M | 2012-08-22 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 457,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 134,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 58,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 107.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | AssetRetirementObligation | Asset Retirement Obligation | USD | 953,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007633 | |
| us-gaap | AssetRetirementObligationAccretionExpense | Asset Retirement Obligation, Accretion Expense | USD | 87,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007633 |
| us-gaap | AssetRetirementObligationLiabilitiesIncurred | Asset Retirement Obligation, Liabilities Incurred | USD | 88,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001564590-19-004275 |
| us-gaap | Assets | Assets | USD | 18.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 11.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Assets, Current | USD | 190,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018253 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 95.39M | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003950 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 164.64M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 2,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 153,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 164.79M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 279.80M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219482 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219482 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 279.80M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost | USD | 9.62M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 9.62M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 9.61M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 9.61M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 |
| us-gaap | CapitalLeaseObligations | Capital Lease Obligations | USD | 738,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeaseObligationsCurrent | Capital Lease Obligations, Current | USD | 490,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009854 |
| us-gaap | CapitalLeaseObligationsNoncurrent | Capital Lease Obligations, Noncurrent | USD | 248,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDue | Capital Leases, Future Minimum Payments Due | USD | 803,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueCurrent | Capital Leases, Future Minimum Payments Due, Next Twelve Months | USD | 540,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueInFiveYears | Capital Leases, Future Minimum Payments Due in Five Years | USD | 0 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueInFourYears | Capital Leases, Future Minimum Payments Due in Four Years | USD | 0 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueInThreeYears | Capital Leases, Future Minimum Payments Due in Three Years | USD | 29,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueInTwoYears | Capital Leases, Future Minimum Payments Due in Two Years | USD | 234,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueThereafter | Capital Leases, Future Minimum Payments Due Thereafter | USD | 0 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments | Capital Leases, Future Minimum Payments, Interest Included in Payments | USD | 65,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | CapitalUnitsAuthorized | Capital Units, Authorized | shares | 520.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | Cash | Cash | GBP | 0 | 2017-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001564590-19-004275 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 4.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 31.25M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 9.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 4.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -4.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 901,812 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 10.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 10.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | CommonStockValueOutstanding | Common Stock, Value, Outstanding | USD | 2.20M | 2013-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -11.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -9.08M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003950 |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 16.39M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 12.20M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | ContractualObligationDueInFifthYear | Contractual Obligation, to be Paid, Year Five | USD | 996,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | ContractualObligationDueInFourthYear | Contractual Obligation, to be Paid, Year Four | USD | 966,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 372,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 911,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | ContractualObligationDueInThirdYear | Contractual Obligation, to be Paid, Year Three | USD | 938,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 513,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 513,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 605,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod | Contract with Customer, Performance Obligation Satisfied in Previous Period | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 12.30M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 580,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 13.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 364,000 | 2018-12-31 | 2020 | Q1 | 10-Q | 2020-05-06 | 0001564590-20-021960 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 28,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 31,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 3,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | DebtInstrumentIncreaseAccruedInterest | Debt Instrument, Increase, Accrued Interest | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001564590-17-003792 |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | DeferredIncomeAddition | DeferredIncomeAddition | USD | 38.17M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 |
| us-gaap | DeferredIncomeCurrent | Deferred Income, Current | USD | 775,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | DeferredIncomeNoncurrent | Deferred Income, Noncurrent | USD | 77.00M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-08 | 0000950170-23-002185 | |
| us-gaap | DeferredIncomeRevenueRecognized | DeferredIncomeRevenueRecognized | USD | 7.78M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 1.00M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-276219 | |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 356.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 1.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 289.52M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 1.20B | 2024-12-31 | 2024 | FY | 10-K | 2025-03-07 | 0000950170-25-035507 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 15.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 1.05B | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007633 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 10.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 8.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 106.90M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-08 | 0000950170-23-002185 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpense | Deferred Tax Assets, Tax Deferred Expense | USD | 41.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 99,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements | USD | 1.38M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001564590-19-004275 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 355.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxExpenseFromStockOptionsExercised | Deferred Tax Expense from Stock Options Exercised | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 1.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007633 | |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.06 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.5 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | Depreciation | Depreciation | USD | 400,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 46,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | DilutiveSecurities | Dilutive Securities, Effect on Basic Earnings Per Share | USD | 0 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039820 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Assets, Noncurrent | USD | 51.43M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018253 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationConsideration | Disposal Group, Including Discontinued Operation, Consideration | USD | 94.80M | 2022-04-04 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets | Disposal Group, Including Discontinued Operation, Other Assets, Current | USD | 190,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities | Disposal Group, Including Discontinued Operation, Other Liabilities, Current | USD | 39,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-08 | 0000950170-23-002185 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets | Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent | USD | 39,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities | Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent | USD | 960,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018253 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent | Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current | USD | 190,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-08 | 0000950170-23-002185 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent | Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent | USD | 44.30M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 | |
| us-gaap | DisposalGroupNotDiscontinuedOperationGainLossOnDisposal | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 |
| us-gaap | DividendsCommonStockStock | Dividends, Common Stock, Stock | USD | 400,000 | 2023-10-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.76 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.87 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018253 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.76 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.436 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009854 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.162 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.268 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations | Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 471,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 66,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | FinanceLeaseInterestPaymentOnLiability | Finance Lease, Interest Payment on Liability | USD | 66,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-07 | 0000950170-25-035507 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 2.67M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueAfterYearFive | Finance Lease, Liability, to be Paid, after Year Five | USD | 0 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 947,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFive | Finance Lease, Liability, to be Paid, Year Five | USD | 0 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 0 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 436,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 1.28M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 151,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041368 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 280,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 250,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 240,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.104 | 2025-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219482 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | 50.24M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-08 | 0000950170-23-002185 |
| us-gaap | GainLossOnSaleOfProperties | Gain (Loss) on Sale of Properties | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -21,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007633 |
| us-gaap | GainLossOnSalesOfAssetsAndAssetImpairmentCharges | Gain (Loss) on Sale of Assets and Asset Impairment Charges | USD | 50.24M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | 1.17M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 10.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | 32.74M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -11.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -18,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -3.49 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027095 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 190,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 1,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -14.26M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 496,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | 6.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 17,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 3,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -103,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 635,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -562,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -203,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 59,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -800,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInIncomeTaxes | Increase (Decrease) in Income Taxes | USD | -92,000 | 2014-01-01 | 2014-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -10.65M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -809,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 1.10M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023005 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | -1.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | 121,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -113,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 1,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -110,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 25,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -169,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039820 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 1.20M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 |
| us-gaap | IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible | Increase in Unrecognized Tax Benefits is Reasonably Possible | USD | 1.10M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-04 | 0001564590-16-027509 | |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 696,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 |
| us-gaap | InterestExpense | Interest Expense | USD | 1.02M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 |
| us-gaap | InterestIncomeOperating | Interest Income, Operating | USD | 132,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 125,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | InterestIncomeRelatedParty | Interest Income, Related Party | USD | 2,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001564590-17-003792 |
| us-gaap | InterestPaidCapitalized | Interest Paid, Capitalized, Investing Activities | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009854 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 421,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 763,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-01 | 0000950170-23-057147 | |
| us-gaap | InterestReceivable | Interest Receivable | USD | 100,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125389 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | InvestmentIncomeAmortizationOfPremium | Investment Income, Amortization of Premium | USD | 358,000 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003950 |
| us-gaap | InvestmentIncomeInterestAndDividend | Investment Income, Interest and Dividend | USD | 199,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 71,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 12.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 3.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 414,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 2.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 650,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041368 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 2.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | Liabilities | Liabilities | USD | 56.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 18.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 6.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 13.00M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001564590-19-004275 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Liabilities, Current | USD | 252,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018253 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent | Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | USD | 8.33M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018253 | |
| us-gaap | LicenseCosts | License Costs (Deprecated 2018-01-31) | USD | 4.50M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023005 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 8.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 296.01M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011469 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -5.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -249.92M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011469 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -7.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -34.82M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011469 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -11.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 | New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) | USD | 400,000 | 2018-07-31 | 2018 | FY | 10-K | 2019-02-26 | 0001564590-19-004275 | |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 1.08M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -148,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 148.62M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039820 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -11.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 586,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 4.13M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 9.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 8.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 655,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 6.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 10.16M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.11M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals | Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals | USD | 18,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001564590-17-003792 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 1.38M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 1.34M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 1.55M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 1.67M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 3.12M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 375,000 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-04 | 0001564590-16-027509 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 2.20M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009854 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.088 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 20.60M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 330,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 705,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 762,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | 151,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -2,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 3.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 1.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | OtherLongTermDebtCurrent | Other Long-term Debt, Current | USD | 100,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 750,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -164,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -14,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 890,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009854 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 1.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | PaymentsForRoyalties | Payments for Royalties | USD | 420,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 19,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-11 | 0000950170-25-106550 |
| us-gaap | PaymentsToAcquireLeaseReceivables | Payments to Acquire Lease Receivables | USD | 31.00M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-08 | 0000950170-23-002185 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 9.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 20.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 16.05M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023248 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 800,000 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-04 | 0001564590-17-008828 | |
| us-gaap | PrepaidRoyalties | Prepaid Royalties | USD | 32.73M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039820 | |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 8.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001564590-17-003792 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001564590-19-030426 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 4,000 | 2012-08-22 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 15.00M | 2025-05-14 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-072040 | |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 63.31M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001564590-19-017599 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | -1,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | 37,000 | 2014-01-01 | 2014-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003950 |
| us-gaap | ProceedsFromRoyaltiesReceived | Proceeds from Royalties Received | USD | 31.00M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-08 | 0000950170-23-002185 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments | Proceeds from Sale, Maturity and Collection of Short-term Investments | USD | 3.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ProceedsFromSaleOfMachineryAndEquipment | Proceeds from Sale of Machinery and Equipment | USD | 94.77M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-08 | 0000950170-23-002185 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 393,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 12.51M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001564590-19-017599 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 250,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-04 | 0001564590-16-027509 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 13,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -11.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 286,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 38,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits | Property Subject to or Available for Operating Lease, Number of Units | Property | 3 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | RepaymentOfNotesReceivableFromRelatedParties | Repayment of Notes Receivable from Related Parties | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001564590-17-003792 |
| us-gaap | RepaymentsOfLongTermCapitalLeaseObligations | Repayments of Long-term Capital Lease Obligations | USD | 98,000 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001564590-19-017599 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 2.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 20.89M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 4.50M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 1.30M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023248 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 1.40M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027095 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 194,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027095 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 1.20M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027095 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 146,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-07 | 0000950170-25-035507 | |
| us-gaap | RestrictedStockValueSharesIssuedNetOfTaxWithholdings | Restricted Stock, Value, Shares Issued Net of Tax Withholdings | USD | -1,000 | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.23 | 2026-06-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 767,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 594,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 100,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023248 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -2.03B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 2.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 120.77M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 500,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | Revenues | Revenues | USD | 1.15M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 4.80M | 2022-04-04 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 50.80M | 2022-04-04 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount | Settlement of Asset Retirement Obligations Through Noncash Payments, Amount | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009854 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 800,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 66,153 | 2014-01-04 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001564590-14-005463 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 8.593 | 2014-01-04 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001564590-14-005463 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 966,190 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001564590-14-005463 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 3.561 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001564590-14-005463 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 36,058 | 2014-01-04 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001564590-14-005463 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.404 | 2014-01-04 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001564590-14-005463 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.142 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.04 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 30.00M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011469 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 64,476 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 190.54 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 100,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 7,814 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 16,500 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 9.2 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 23,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 64,476 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 190.54 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 85.25M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011469 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 64,476 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 190.54 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 2.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent | Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | pure | 1 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001564590-15-009779 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 20.02 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011469 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 202.18 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 34.37 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011469 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 6.61 | 2025-05-31 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 5.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 42,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -37.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) | USD | 339.22M | 2018-12-31 | 2020 | Q1 | 10-Q | 2020-05-06 | 0001564590-20-021960 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.769 | 2014-07-08 | 2014-07-09 | 2015 | FY | 10-K | 2016-03-04 | 0001564590-16-014061 |
| us-gaap | StockholdersEquityNoteSubscriptionsReceivable | Stockholders' Equity Note, Subscriptions Receivable | USD | 335,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 1.19M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007027 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 59,761 | 2014-09-01 | 2014-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001564590-17-023005 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 834,237 | 2025-05-31 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | StockIssuedDuringPeriodSharesOther | Stock Issued During Period, Shares, Other | shares | 59,761 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | StockIssuedDuringPeriodSharesPeriodIncreaseDecrease | Stock Issued During Period, Shares, Period Increase (Decrease) | shares | 1.30M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | shares | 281,826 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensation | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | shares | 644,710 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 15,989 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-28 | 0000950170-24-037644 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 74.57M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001564590-17-003792 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 160,000 | 2019-07-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041368 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForCash | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | USD | 56.46M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 865,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 750,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 70,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001564590-17-003792 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 12,000 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 439,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 |
| us-gaap | SupplementalUnemploymentBenefitsSeveranceBenefits | Supplemental Unemployment Benefits, Severance Benefits | USD | 800,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346885 | |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 1,000 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003950 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 61.09M | 2013-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 102.77M | 2013-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-26 | 0001564590-15-001038 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -11,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-12 | 0001564590-14-005463 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 38.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 133,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | 800,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001564590-18-003390 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007633 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 13.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-108361 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 134,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 14.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 100.73M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018253 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 14.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001104659-26-125192 |